GF Fund Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$47.5K Hold
5,303
﹤0.01% 418
2025
Q1
$39.8K Buy
5,303
+954
+22% +$7.16K ﹤0.01% 441
2024
Q4
$32.7K Buy
+4,349
New +$32.7K ﹤0.01% 429